You are here

American Journal of Alzheimer's Disease & Other Dementias®

American Journal of Alzheimer's Disease & Other Dementias®

2018 Impact Factor: 1.464
2018 Ranking: 168/199 in Clinical Neurology | 44/53 in Geriatrics & Gerontology
Source: Journal Citation Reports (Web of Science Group, 2019)

Editor
Raymond Chuen-Chung Chang, PhD The University of Hong Kong, Hong Kong, China


eISSN: 19382731 | ISSN: 15333175 | Current volume: 34 | Current issue: 6 Frequency: 8 Times/Year
American Journal of Alzheimer's Disease and Other Dementias® (AJADD) accepts original papers from professionals and researchers on the frontlines of Alzheimer's care, dementia, and clinical depression, including those who deal with Alzheimer's patients every day. In every issue, you will find down-to-earth clinical information on:

  • The latest research on Alzheimer's disease from the molecular underpinnings of the disease to its associated behaviors.
  • Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia.
  • New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias.
  • Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences.
  • Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process.
  • Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.

By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to American Journal of Alzheimer's Disease and Other Dementias® today!

This journal is a member of the Committee on Publication Ethics (COPE).

From 1st January 2020, American Journal of Alzheimer's Disease and Other Dementias (AJADD) will become a fully open access journal. 

To facilitate this transition, all articles first submitted on or after 1st August 2019 will be subject to an open access article processing charge (APC) of 1,500 USD (plus tax where applicable), discounted from the full rate of 2,000 USD for a limited time, and will be published under a Creative Commons licence. The APC will be payable on acceptance if the article is accepted after peer review.

American Journal of Alzheimer's Disease and other Dementias® (AJADD) offers an open access, multi-disciplinary peer-reviewed, international forum for researchers, physicians, nurses, psychiatrists, nursing home and assisted living administrators, and other healthcare professionals who deal with patients with dementias every day. AJADD publishes original research, case studies and media reviews on all aspects of Alzheimer's and dementia, including:

  • Basic Research
  • Behavior Management
  • Caregiving
  • Communication strategies
  • Evaluation
  • Heredity
  • Long-term care
  • Memory loss
  • Pharmacotherapy
  • Psychosocial Issues
  • Recreation and activity
  • Therapy
  • Restraint-free care
  • Special care units
  • Symptom management
Editor-in-Chief
Raymond Chuen-Chung Chang, PhD The University of Hong Kong, Hong Kong, China
Editorial Board Members
Norman Abeles, PhD Michigan State University, USA
Carmela Abraham, Phd Boston University - School of Medicine, USA
Sally Albrecht, MA President, Activities and Interventions in Dementia, Inc. (AID)
Donna L.Algase, PhD, RN, FAAN, FGSA University of Michigan, Ann Arbor, MI, USA
Gjumrakch Aliev, MD, PhD University of Atlanta, USA
Myra A Aud Sinclair School of Nursing, University of Missouri, Columbia, MO, USA
Francois Boller, MD, PhD George Washington University, School of Medicine and Health Sciences, USA
Amy R Borenstein, PhD, MPH University of California-San Diego, USA
Heiko Braak, MD Center for Biomedical Research, University of Ulm , Germany
John CS Breitner, MD. MPH University of Washington, Seattle, USA
Maria T Caserta, PhD, MD University of Illinois at Chicago School of Medicine, USA
Neelima B Chauhan, PhD University of Illinois, Chicago, IL, USA
Yuzhi Chen, PhD University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
Bruce A Citron, PhD Bay Pines VA Healthcare System, USA
Malka Cohen-Armon, DSc Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
John Cotter, PhD Virginia Commonwealth University, USA
José R. Criado, PhD Scripps Research Institute, USA
Jeffrey L. Cummings, MD Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA
Neal E. Cutler, PhD American Institute of Financial Gerontology, USA
Stephen Cutler, PhD University of Vermont, USA
Peter Davies, PhD Albert Einstein College of Medicine, USA
John F Disterhoft, MD Feinberg School of Medicine, Northwestern University, USA
Jon Dobson, PhD University of Florida, USA
Tomasz Dziedzic, PhD, MD Jagiellonian University Medical College, Poland
Piet Eikelenboom, MD Vrije Universiteit Amsterdam, Netherlands
Carl Eisdorfer, PhD, MD Duke University School of Medicine, USA
Carol J Farran, DNSc, RN, FAAN Rush University, College of Nursing, USA
Lindsey A Farrer, PhD Boston University School of Medicine, USA
F. Richard Ferraro, PhD University of North Dakota, USA
Maria E Figueiredo-Pereira, PhD CUNY - City University of New York, USA
Alan Fine, PhD Dalhousie University, Canada
Pierluigi Gambetti, MD Case Western Reserve University School of Medicine, USA
Cheng-Xin Gong, MD, MS CUNY - City University of New York, USA
Iliana Gozes, PhD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Steven M Greenberg, MD, PhD Massachusetts General Hospital, USA
Xianlin Han, PhD UT Health San Antonio, USA
Ying Han, MD, PhD Xuan Wu Hospital, Capital Medical University, China
Victor W Henderson, MD, MS Stanford University, USA
Kenneth W Hepburn, PhD Emory University, USA
Yeun-Shan Ho, PhD The Hong Kong Polytechnic University, Hong Kong, China
Bradley T Hyman, MD, PhD Massachusetts General Hospital, USA
Shannon E Jarrott, PhD The Ohio State University, College of Social Work, USA
Henry Ka-Fung Mak, PhD The University of Hong Kong, Hong Kong, China
Joanne Koenig-Coste, M.Ed Alzheimer Consultant, USA
Christine R Kovach, PhD, RN University of Wisconsin-Milwaukee, USA
Daniel Kuhn, MSW University of Michigan School of Social Work, USA
Shupeng Li, PhD Shenzhen Graduate School of Peking University, China
Mary Lucero Geriatric Resources, Inc.
Colin L Masters, MD Florey Institute of Neuroscience and Mental Health, Australia
Richard Mayeux, MD, MSc Columbia University, USA
Patrizia Mecocci, MD, PhD University of Perugia, Italy
Rita Moretti, MD University of Trieste, Italy
Judith R O'Jile, PhD UNT Health Science Center, USA
Paul Raia, PhD Alzheimer’s Association MA/NH Chapter, USA
Stephen A Rappaport, MD Indiana University Health, USA
Barry Reisberg, MD Aging and Dementia Research Center, New York, New York, USA
Gerard D Schellenberg, PhD Perelman School of Medicine, University of Pennsylvania, USA
Dennis J Selkoe, MD Brigham and Women's Hospital, Harvard Medical School, USA
Rebecca Sleeper, PharmD Texas Tech University Health Sciences Center, USA
Joan Swearer, MD University of Massachusetts Medical School, USA
John Q Trojanowski, MD, PhD University of Pennsylvania, USA
Ian Trounce, PhD Centre for Eye Research Australia, Australia
Magda Tsolaki, MD Papanikolaou General Hospital of Thessalonikii, Greece
Holly A Tuokko, PhD University of Victoria, Canada
Christine Van Broeckhoven, MD University of Antwerpen, Belgium
Jian-Zhi Wang, Phd Huazhong University of Science and Technology, China
Bengt Winblad, MD, PhD Huddinge Hospital, Sweden
Xifei Yang, PhD Shenzhen Center for Disease Control and Prevention, China
Ying Yang, PhD Huazhong University of Science and Technology, China
Jeremy Yorgason, PhD Brigham Young University, USA
Steve H Zarit, PhD The Pennsylvania State University, USA
Zaijun Zhang, PhD Jinan University College of Pharmacy, China
Guo-Ging Zheng, MD, PhD Wenzhou Medical College, China
  • CINAHL
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Index Medicus
  • MEDLINE
  • NISC
  • ProQuest
  • PsycINFO
  • SafetyLit
  • SciSearch
  • Science Citation Index Expanded (Web of Science)
  • Scopus
  •  

    Before you submit your research, please make sure your paper meets the below criteria:

     

    1. Your paper is an original work and has not been published or currently under review with another journal.

    2. A cover letter is included with the following criteria:

    1. Letters must be on an institutional letter head
    2. Letters should be addressed to the Editor-in-Chief, Dr. Chang
    3. Letters must be signed by corresponding author
    4. Authors must point out the key message if the manuscript and what is the uniqueness of the study
    5. A note stating agreement of all authors of submission

    3. Only authors that have contributed to the work are added. Please see ICMJE's guidelines "Defining Roles of Authors and Contributors". 

    4. Your work meets all Research Ethics and Reporting Standards. 

    5. Your figures are of acceptable quality and uploaded as separate files. Line art should be 900-1200 DPI, images 300 DPI. Images should be minimally processes to uphold their original integrity. More figure information here.  

    6. Your references are formatted correctly and numbered as they appear in the text. Please visit here for reference style.  

    7. Please add at least three recommended reviewers with the following criteria:

    1. Recommended reviewers should be experts in their fields and should be able to provide an objective  assessment of the manuscript
    2. The reviewer should have no prior knowledge of your submission
    3. The reviewer should not have recently collaborated with any of the authors
    4. Reviewer nominees from the same institution as any of the authors are not permitted
    5. Reviewer should not be from the same country as the authors
    6. No two reviewers should be from the same university

    8. Authors must have an understanding and agreement to pay any applicable article processing charges (APCs).

    From 1st January 2020, American Journal of Alzheimer's Disease and Other Dementias (AJADD) will become a fully open access journal. 

    To facilitate this transition, all articles first submitted on or after 1st August 2019 will be subject to an open access article processing charge (APC) of 1,500 USD (plus tax where applicable), discounted from the full rate of 2,000 USD for a limited time, and will be published under a Creative Commons licence. The APC will be payable on acceptance if the article is accepted after peer review.

    9. Only manuscripts of sufficient quality that meet the aims & scope of the journal will be reviewed.

    Submissions that don't adhere to these instructions will be returned prior to peer review. 

    Once your manuscript meets all criteria above and below, you can submit it through our online submission system here.

     

    This journal is a member of the Committee on Publication Ethics (COPE).

     

     

    Manuscript Preparation and Submission Guidelines

    Manuscripts should be submitted to http://mc.manuscriptcentral.com/ajad

    Files should be submitted in Microsoft Word and should include the following elements: complete author names, author contact information, author credentials and affiliations, acknowledgments, abstract (150 words or less), keywords, references, tables, illustrations, and legends. The format and style of the manuscript should follow the guidelines of AMA manual of style (10th ed.). There is no word limit or page count for manuscripts submitted to this journal.

    American Journal of Alzheimer's Disease and Other Dementias® operates a conventional single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. A minimum of two reviewers consider each manuscript. 

    For details of manuscript preparation not covered herein, please examine recent issues of the journal. American Journal of Alzheimer's Disease and Other Dementias® does not accept qualitative research, case reports, or systematic reviews for publication.

    Submission Process

    User Account 
    The Manuscript Central program asks authors to generate an author/reviewer account if one has not been created already. Authors are required to supply their first and last names, email addresses, and keywords chosen from a list of those used previously in the journal.

    Title, Abstract, and Keywords
    Authors first supply the manuscript title and an abstract. The title should be reasonably short and communicate the main idea of the research. The abstract should not be longer than 150 words and should substantively summarize the article. Five keywords to facilitate electronic access to this manuscript should be listed after the abstract.Given that researchers increasingly rely upon Google Scholar and other search engines, choice of appropriate keywords is imperative to encourage downloads and citations.

    Figures and Tables 
    All figures and tables should have a title and numbered tables should be placed at the end of the file, following text and references, with callouts for each in the text. Elements in tables should be separated by tabs, not cells or lines. High-resolution figures should be uploaded as separate electronic files, with callouts for each in the text. Acceptable file formats for figures include TIFF, EPS, and JPEG, and PDF Microsoft Application Files are acceptable for vector art (line art). (Please do not send glossies).

    Figures should be numbered consecutively in the order in which they appear in the text and must include figure captions. Figures will appear in the published article in the order in which they are numbered initially. The figure resolution should be 300 dpi at the time of submission.

    Tables should be structured properly. Each table must have a clear and concise title. They should be numbered consecutively in the order in which they appear in the text. For each Table, there must be a corresponding citation in the text and for each Table citation here must be a corresponding table. 

    References 
    Authors are responsible for correctness and completeness of references.

    For each text citation there must be a corresponding reference in the reference list and for each reference there must be a corresponding text citation. Cite references in consecutive order using superscript Arabic numbers. Each superscript must match one reference in the References list. Use commas to separate multiple citation numbers in text. Corresponding references should be listed in numeric order at the end of the document. Unpublished works and personal communications (oral, written, and electronic) should be cited parenthetically (and not on the reference list). Superscript numbers are placed outside periods and commas, and inside colons and semicolons. When more than 2 references are cited at a given place in the manuscript, use hyphens to join the first and last numbers of a closed series; use commas without space to separate other parts of a multiple citation.

    Basic rules for the reference list are:

    • The title “References” is centered at the top of a separate page at the end of the document.
    • Entries are preceded by their number and are given in numerical order.
    • The reference list should be single-spaced. Single-space between entries.

    Do not use “et al.” in the Reference list at the end; names of all authors of a publication should be listed there.

    References should be typed in the style adopted by the American Medical Association. For example:

    Books

     

    Author(s) separated by commas. Title of Book. Place of publication: Publisher; year.

    Goldberg L, Elliot DL. Exercise for Prevention and Treatment of Illness. Philadelphia, Pa: FA Davis Co; 1994.

    Edited book

    Author(s), eds. Title of Book. Place of publication: Publisher; year.

    Armitage JO, Antman KH, eds. High Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells. Baltimore, Md: Williams & Wilkins; 1995.

    Chapter or article from a book

    Author(s) of article. Title of article. In: Editor's name, ed. Title of Book. Place of publication: Publisher; Year: Chapter or page number.

    Gamble VN. On becoming a physician: a dream not deferred. In: White EC, ed. The Black Women's Health Book: Speaking for Ourselves. Seattle, Wash: Seal Press; 1990:52-64.

      

    Ethical Guidelines
    Funding

    American Journal of Alzheimer's Disease and Other Dementias® requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    Declaration of conflicting interests

    It is the policy of American Journal of Alzheimer's Disease and Other Dementias® to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    Clinical trials

    American Journal of Alzheimer's Disease and Other Dementias® conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

    Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

    Permission Guidelines
    Authors are solely responsible for obtaining all necessary permissions and for paying any associated fees. Permission must be granted in writing by the copyright holder and must accompany the submitted manuscript. Authors are responsible for the accuracy of facts, opinions, and interpretations expressed in the article.

    All published materials are copyrighted by Sage Publications, Inc. Every lead author must sign an electronic contract before an article can be published.

    Authors who would like to refine the use of English in their manuscripts might consider using Sage Language Services. This service is open to any authors who need assistance cleaning up their paper and are willing to pay professionals for help. Please note that using this service does not guarantee acceptance into the journal, but is intended a resource for editing, translating, figure and text formatting, and other manuscript preparation needs.

    ORCID
    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID iD please follow this link to create one or visit our ORCID homepage to learn more.

    1. Letters must be on an institutional letter head
    2. Letters should be addressed to the Editor-in-Chief, Dr. Chang
    3.  Letters must be signed by corresponding author
    4. Authors must point out the key message if the manuscript and what is the uniqueness of the study
    5. A note stating agreement of all authors of submission

    For more details, please review the submission guidelines.

    Inquiries may be directed to:

    Elaine Ellerton, PhD
    Managing Editor
    elaine.ellerton@sagepub.com


    Submissions should be sent to: http://mc.manuscriptcentral.com/ajad

     

     

     

     

     

     

    Individual Subscription, Print Only


    Hospital Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue